SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Geriatric Psychiatry and Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sommer, H.
Right arrow Articles by Harrer, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sommer, H.
Right arrow Articles by Harrer, G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Placebo-Controlled Double-Blind Study Examining the Effectiveness of an Hypericum Preparation in 105 Mildly Depressed Patients

H. Sommer

G. Harrer

One hundred and five outpatients with mild depressions of short duration were treated in a double-blind study with either 3 x 300 mg hypericum extract or placebo. The therapy phase was 4 weeks. The effectiveness was judged according to the Hamilton Depression Scale after 2 and 4 weeks. The values of the mean basic score in these periods fell from 15.8 to 9.6 or 7.2 in the active group, and in the placebo group, from 15.8 to 12.3 and 11.3. The differences between active and placebo groups were statistically significant with P < .05 and P < .01 achieved after 2 and 4 weeks, respectively. In the active group, 28 of 42 patients (67%) and, in the placebo group, 13 of 47 patients (28%) responded to treatment. Notable side effects were not found. (J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S9-S11).

Journal of Geriatric Psychiatry and Neurology, Vol. 7, No. 1, S9-S11 (1994)
DOI: 10.1177/089198879400700104
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
K. LINDE, M. BERNER, M. EGGER, and C. MULROW
St John's wort for depression: Meta-analysis of randomised controlled trials
The British Journal of Psychiatry, February 1, 2005; 186(2): 99 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
I. Mai, E. Stormer, S. Bauer, H. Kruger, K. Budde, and I. Roots
Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients
Nephrol. Dial. Transplant., April 1, 2003; 18(4): 819 - 822.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil
International Journal of Toxicology, January 1, 2001; 20(2_suppl): 31 - 39.
[Abstract] [PDF]


Advertisement